Essex Woodlands IX, LLC, 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT), sold 447,872 shares at $11.09 ($5.0M) on 2023-08-25, disclosed to the SEC on 2023-08-30.
Open-market sale of $5.0M EYPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.56 | 52,180 | $551K | 11.1% |
| 2 | $10.56 | 52,180 | $551K | 11.1% |
| 3 | $11.54 | 87,100 | $1.0M | 20.2% |
| 4 | $11.54 | 87,100 | $1.0M | 20.2% |
| 5 | $10.45 | 11,731 | $123K | 2.5% |
| 6 | $10.45 | 11,731 |
| $123K |
| 2.5% |
| 7 | $11.09 | 72,925 | $809K | 16.3% |
| 8 | $11.09 | 72,925 | $809K | 16.3% |
| Total | $11.11 avg | 447,872 | $5.0M | 100% |
| Filing → |
| EYPT | BUY | 2018-07-03 | $42.8M | — | Filing → |